资讯
来自MSN17 天
Regeneron, Sanofi Say Their Inflammation Drug Approved By FDA For Rare Skin Disease ... - MSNRegeneron, Sanofi Say Their Inflammation Drug Approved By FDA For Rare Skin Disease Affecting Elderly, But Retail Stays Dull© Stocktwits REGN's Sentiment Meter and Message Volume as of 9:30 a.m ...
In February 2025, Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA ...
The simplicity of the new monoclonal Enflonsia could give it an advantage over AstraZeneca’s Beyfortus Enflonsia, a monoclonal antibody for RSV, is approved for use in children under 12 months ...
Newly FDA-approved HIV prevention drug, Yeztugo, offers protection for six months—yet the need for a vaccine remains, say experts. Thursday, June 19th 2025, 6:07 am By: CBS News ...
Merck & Co – known as MSD outside the US and Canada – has announced that its respiratory syncytial virus (RSV) preventive monoclonal antibody has been approved by the US Food and Drug Administration ...
Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S. Food and Drug Administration (FDA ...
Lab-grown salmon is now FDA approved — here’s why this one restaurant is putting it on the menu By Caroline Cubbin Published June 10, 2025, 8:02 p.m. ET ...
Cinclus Pharma Holding AB (publ) is a late-stage clinical pharmaceutical company developing drugs for the treatment of acid-related diseases and disorders of the upper gastrointestinal tract.
**media [658222]**The FDA's ODD program is designed to support the development and evaluation of new treatments for serious and life-threatening rare diseases affecting fewer than 200,000 people. The ...
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.
Canalevia-CA1 (crofelemer delayed-release tablets) is the first and only oral plant-based prescription product that is FDA conditionally approved to treat chemotherapy-induced diarrhea (CID) in dogs.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果